MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)
- Status
- TERMINATED
- Phase
- PHASE2
AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis
- Status
- UNKNOWN
- Phase
- PHASE3
MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer
- Status
- RECRUITING
- Phase
- PHASE2
QUantitative Assessment of Swallowing After Radiation (QUASAR)
- Status
- UNKNOWN
- Phase
- N/A
Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CIML NK Cell in Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases.
- Status
- UNKNOWN
- Phase
- PHASE2